IGF2R and cervical cancer: These results suggest that pharmacological inhibition of CK2 can regulate the oncogenic functions of IGF2R in cervical cancer cells; however, this study did not show direct interaction of IGF2R and CK2 (e.g. phosphorylation of IGF2R by CK2).